<DOC>
	<DOC>NCT02072408</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of aflibercept for treatment of polypoidal choroidal vasculopathy without active polyp.</brief_summary>
	<brief_title>Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<criteria>polypoidal choroidal vasculopathy without active polyp decreased visual acuity by subretinal fluid and hemorrhage involving foveal center polypoidal choroidal vasculopathy with active polyp previous photodynamic therapy more than three times antiVEGF injection within one month photodynamic therapy or intraocular steroid treatment within three months</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>